Mr Mrs Miss Ms Dr Other

Dr
Adam
Hines

Partner

York Office

Engineering

Telephone. +44(0) 1904 732 120
Mobile. +44(0) 776 639 2285
Email. [email protected]
UPC Representative
Our team of specialist European patent litigators, oppositions specialists and patent attorneys bring together an extensive depth of legal and technical knowledge and are qualified to represent you in the UPC.

Experience

Adam is a commercially-minded attorney with considerable experience of building, optimizing and defending patent portfolios.

Having previously managed an extensive patent portfolio at a multinational healthcare company, Adam is adept at developing harmonized, robust global IP strategies that complement the commercial goals of his clients and add value to their business.

European patent oppositions are a core aspect of Adam’s work. He has a wealth of knowledge in this area having represented clients at over 50 hearings before the European Patent Office both attacking and defending business-critical patents. Adam enjoys the challenging, dynamic and adversarial nature of the opposition process and has an established track record in achieving favourable outcomes for his clients.

Adam is dedicated to providing insightful and pragmatic advice to clients across a range of different industries and specializes in the field of medical technology and medical devices.

Qualifications

Patent Attorney

Chartered (UK)
Europe


BSC

Chemistry with Medicinal Chemistry

MSC

Toxicology

PHD

PhD in Biochemistry and Environmental Metabolomics

Publications

Innovation at the heart of UK medtech strategy

View publication online

Health-conscious IP strategies

View publication online

The Internet of Medical Things

View publication online

Conferences: 2021

November 3rd 2021

Challenging granted patents: a comparison between Europe and the US

Speaker

Event details

June 9th 2021

Webinar: Developing effective patent strategies for personalised medical devices in Europe and the US

Speaker

Event details

January 14th 2021

HGF IP in Healthcare Virtual Conference 2021

Speaker

Event details

Related News

Agritech Thymes: Exploring the Agritech IP landscape – past trends and future insights

The agrifood patent landscape analysis recently reported by WIPO provides interesting insights into key areas of innovation and the IP strategies being adopted. The agrifood industry, encompassing both agritech and …

Read article
Event - 8th, 22nd February 2024

Dresden & Salzburg Seminar: Patent applications and grants in Europe

HGF is pleased to invite you to our upcoming German-language seminar on “Patent applications and grants in Europe” in Salzburg and Dresden. The seminar provides participants with a comprehensive overview …

Event details
Event - 10th October 2024

Webinar: Patents and business activities in harmony

In today’s highly competitive world, patents are not only a legal tool but also a strategic instrument to strengthen your market position and maximise your business success. But how do …

Event details
Event - 8th, 22nd February 2024

Dresden & Salzburg Seminar: Basics of trade mark protection - National and European perspectives

HGF is pleased to invite you to our upcoming German speaking seminar on “Fundamentals of trade mark protection: National and European Perspectives” in Salzburg and Dresden. The seminar will cover …

Event details

EPO Annual Fee Increases

The European Patent Office (EPO) has announced that revised Official Fees will apply to payments made on or after Monday 1st April 2024. The majority of fees will increase by …

Read article
Event - 30th January 2024

CAR-TCR Summit, Europe 2024

HGF are proud Event Partners of CAR-TCR Europe, which is due to go ahead from 27th – 29th February at ExCeL, Royal Victoria Dock in London. This is the European hub …

Event details

How to Use IP Strategy to Tip the Odds in Your Favour

Porter’s Five Forces model [1] is just one example of a convenient model for exploring and understanding the forces at play in a competitive marketplace. Michael Porter’s Five Forces model …

Read article

First CRISPR therapy approved for use in the UK

In an unprecedented move, the MHRA has approved a CRISPR gene editing therapy ‘Casgevy’  for the treatment of sickle cell disease and beta-thalassaemia in patients with recurrent vaso-occlusive crises. The Casgevy …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.